These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38330155)

  • 1. The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis.
    Akhavanrezayat A; Uludag Kirimli G; Matsumiya W; Khojasteh H; Or C; Karaca I; Pham B; Ongpalakorn P; Lajevardi S; Lam B; Hwang JJ; Than NTT; Park S; Yavari N; Bazojoo V; Mobasserian A; Khatri A; Halim MS; Thng ZX; Ghoraba H; Do DV; Tugal-Tutkun I; Gupta V; de Smet M; Nguyen QD
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1832-1843. PubMed ID: 38330155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
    Agrawal R; Testi I; Lee CS; Tsui E; Blazes M; Thorne JE; Okada AA; Smith JR; McCluskey PJ; Kempen JH; Tappeiner C; Agarwal M; Bodaghi B; Nguyen QD; Gupta V; De Smet MD; Zierhut M; Pavesio C;
    Br J Ophthalmol; 2021 May; 105(5):639-647. PubMed ID: 32586933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology.
    Değirmenci MFK; Yalçındağ FN; Tugal-Tutkun İ
    Turk J Ophthalmol; 2021 Aug; 51(4):231-242. PubMed ID: 34461710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of non-infectious uveitis treated with and without systemic immunomodulatory therapy.
    Felfeli T; Eshtiaghi A; Rhee J; Balas M; Tai F; Kaplan AJ; Christakis PG; Dzulynsky K; Monson H; Mandelcorn ED; Rubin LA; Bakshi NK; Derzko-Dzulynsky LA
    Can J Ophthalmol; 2024 Oct; 59(5):358-366. PubMed ID: 37972648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.
    Okada AA
    Ocul Immunol Inflamm; 2005; 13(5):335-51. PubMed ID: 16419419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising drug therapy for non-infectious uveitis.
    Shahab MA; Mir TA; Zafar S
    Int Ophthalmol; 2019 Jul; 39(7):1633-1650. PubMed ID: 29961190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY).
    Agarwal AK; Sudharshan S; Mahendradas P; Babu K; Shenoy P; Dogra M; Bansal R; Agarwal M; Biswas J; Balamurugan S; Agrawal R; Gupta V
    Br J Ophthalmol; 2022 Jan; 106(1):97-101. PubMed ID: 33011688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.
    Takeuchi M; Kanda T; Kaburaki T; Tanaka R; Namba K; Kamoi K; Maruyama K; Shibuya E; Mizuki N
    Medicine (Baltimore); 2019 Mar; 98(9):e14668. PubMed ID: 30817592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Therapy in Uveitis.
    Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S
    Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior Uveitis.
    Uy HS; Yu-Keh E; Chan PS
    Dev Ophthalmol; 2016; 55():163-6. PubMed ID: 26502276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histoplasmosis Following Systemic Immunomodulatory Therapy for Ocular Inflammation.
    Starr MR; Smith WM
    Am J Ophthalmol; 2019 Feb; 198():88-96. PubMed ID: 30308204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy Risk Associated With the Use of Systemic Immunomodulatory Therapy in the Management of Noninfectious Uveitis.
    Papaliodis GN; Yu Y; Brill DA; Sobrin L; VanderBeek B
    Am J Ophthalmol; 2024 Sep; 265():241-247. PubMed ID: 38679356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of "Early" Withdrawal of Corticosteroid Sparing Immunomodulatory Therapy for Birdshot Retinochoroidopathy.
    You C; Meese H; Stephenson A; Montieth A; Ma L; Hernandez M; Kubaisi B; Syeda S; Foster CS
    Ocul Immunol Inflamm; 2019; 27(7):1165-1173. PubMed ID: 30207810
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapies in development for the management of non-infectious uveitis: A review.
    Hassan M; Karkhur S; Bae JH; Halim MS; Ormaechea MS; Onghanseng N; Nguyen NV; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Clin Exp Ophthalmol; 2019 Apr; 47(3):396-417. PubMed ID: 30938012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Posterior Infectious Uveitis.
    Curi ALL; de-la-Torre A; Schlaen A; Mahendradas P; Biswas J
    Ocul Immunol Inflamm; 2023 Dec; 31(10):1944-1954. PubMed ID: 38096404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation and TNF-α inhibition for tubulointerstitial nephritis and uveitis syndrome: a case series.
    Tirelli F; Shafer BM; Davidson SL; Lerman MA
    J AAPOS; 2021 Oct; 25(5):267.e1-267.e6. PubMed ID: 34600106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.
    Barry RJ; Tallouzi MO; Bucknall N; Mathers JM; Murray PI; Calvert MJ; Moore DJ; Denniston AK
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012577. PubMed ID: 30562409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.